Bridgefront Capital, LLC Dexcom Inc Transaction History
Bridgefront Capital, LLC
- $278 Million
- Q4 2024
A detailed history of Bridgefront Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Bridgefront Capital, LLC holds 3,759 shares of DXCM stock, worth $334,814. This represents 0.11% of its overall portfolio holdings.
Number of Shares
3,759
Previous 14,196
73.52%
Holding current value
$334,814
Previous $951,000
69.3%
% of portfolio
0.11%
Previous 0.38%
Shares
5 transactions
Others Institutions Holding DXCM
# of Institutions
1,072Shares Held
339MCall Options Held
6.74MPut Options Held
6.33M-
Vanguard Group Inc Valley Forge, PA46.5MShares$4.14 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$3.07 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.49 Billion0.05% of portfolio
-
Baillie Gifford & CO14.6MShares$1.3 Billion0.9% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.4MShares$1.28 Billion0.24% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $34.4B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...